扩大胆管癌的视野:超越FGFR2和IDH1的新兴目标
Lily Darman1,2, Quinn Kaurich2, Md Sazzad Hassan2,3
1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46617, USA.
International journal of molecular sciences
|November 13, 2025
概括
胆管癌 (Cholangiocarcinoma,CCA) 是一种沉默的胆管癌,通常是晚诊断的. 新的向疗法和免疫疗法提供了希望,有几个已获得批准,另一些正在研究,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆管癌 (CCA) 是一种罕见但具有攻击性的胆管癌,通常在晚期被诊断出来.
- 目前晚期CCA的标准治疗方法是吉姆西塔加西斯普拉丁 (GemCis) 化疗,有效性有限.
- 由于晚期CCA的预后不佳,因此急需新的治疗策略.
研究的目的:
- 提供对已批准的和正在研究的针对性治疗对胆管癌的综合性审查.
- 要突出在CCA治疗中被准的分子途径.
- 为CCA治疗的不断变化的景观提供最新的视角.
主要方法:
- 对CCA中向治疗的已批准和临床试验数据的文献综述.
- 对新型药物向的分子通路的分析.
- 综合当前关于免疫疗法和针对性药物开发的CCA研究.
主要成果:
- 几种向疗法 (ivosidenib, pemigatinib, infigratinib, futibatinib) 和免疫疗法 (durvalumab) 都被FDA批准用于CCA.
- 目前正在进行的研究目标是多种分子途径,包括p53/MDM2,JAK/STAT,KRAS,HER2,VEGFR和DNA损伤修复.
- 有前途的进展正在取得,但进一步的研究是必不可少的.
结论:
- 向疗法和免疫疗法是CCA治疗的快速扩展和有前途的领域.
- 对新的分子标和治疗组合的持续研究对于改善患者的治疗结果至关重要.
- 该审查强调了霍兰基癌的不断变化的治疗场景.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K


